title: Angiotensin-converting enzyme inhibitors in the treatment of sarcoidosis and association with ACE gene polymorphism: case series.
abstract: Angiotensin-converting enzyme (ACE) is used as a marker for sarcoid disease activity. We present an observational study of four African-American patients all of whom demonstrated improvement in their sarcoidosis after treatment with ACE inhibitors for hypertension.
authors.affiliation: Department of Medicine, Community Hospital of San Bernardino, California 92411, USA. vkaura50@gmail.com
authors.forename: Vinod
authors.initials: V
authors.lastname: Kaura
authors.forename: Neil V
authors.initials: NV
authors.lastname: Kaura
authors.forename: Bobby N
authors.initials: BN
authors.lastname: Kaura
authors.forename: Claire S
authors.initials: CS
authors.lastname: Kaura
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001552:Benzazepines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D011110:Polymorphism, Genetic; D012507:Sarcoidosis / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics; D014057:Tomography, X-Ray Computed
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D001552:Benzazepines; D007703:Peptidyl-Dipeptidase A; C044946:benazepril